RU2011150950A - METHOD FOR INTEGRATED TREATMENT OF REFRACTION AMBLIOPIA IN HIGH DEGREE MYOPIA PATIENTS - Google Patents

METHOD FOR INTEGRATED TREATMENT OF REFRACTION AMBLIOPIA IN HIGH DEGREE MYOPIA PATIENTS Download PDF

Info

Publication number
RU2011150950A
RU2011150950A RU2011150950/02A RU2011150950A RU2011150950A RU 2011150950 A RU2011150950 A RU 2011150950A RU 2011150950/02 A RU2011150950/02 A RU 2011150950/02A RU 2011150950 A RU2011150950 A RU 2011150950A RU 2011150950 A RU2011150950 A RU 2011150950A
Authority
RU
Russia
Prior art keywords
ambliopia
refraction
high degree
integrated treatment
patients
Prior art date
Application number
RU2011150950/02A
Other languages
Russian (ru)
Other versions
RU2493803C2 (en
Inventor
Виктория Николаевна Красногорская
Елена Викторовна Сорокина
Олег Борисович Замаряхин
Original Assignee
Государственное бюджетное образовательное учреждение высшего профессионального образования "Амурская государственная медицинская академия" Минздравсоцразвития Российской Федерации
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Государственное бюджетное образовательное учреждение высшего профессионального образования "Амурская государственная медицинская академия" Минздравсоцразвития Российской Федерации filed Critical Государственное бюджетное образовательное учреждение высшего профессионального образования "Амурская государственная медицинская академия" Минздравсоцразвития Российской Федерации
Priority to RU2011150950/14A priority Critical patent/RU2493803C2/en
Publication of RU2011150950A publication Critical patent/RU2011150950A/en
Application granted granted Critical
Publication of RU2493803C2 publication Critical patent/RU2493803C2/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Способ комплексного лечения рефракционной амблиопии больных миопией высокой степени, включающий эксимерлазерную рефракционную операцию Эпи-ЛАСИК, отличающийся тем, что в послеоперационном периоде выполняют внутривенные инъекции лекарственного препарата Цераксон (цитидин-5-дифосфохолин) с последующей электростимуляцией сетчатки и зрительного нерва в течение 10 дней.A method for the complex treatment of refractive amblyopia in patients with high myopia, including Epi-LASIK excimer laser refractive surgery, characterized in that in the postoperative period, intravenous injections of the drug Ceraxon (cytidine-5-diphosphocholine) are performed followed by electrical stimulation of the retina and optic nerve for 10 days.

Claims (1)

Способ комплексного лечения рефракционной амблиопии больных миопией высокой степени, включающий эксимерлазерную рефракционную операцию Эпи-ЛАСИК, отличающийся тем, что в послеоперационном периоде выполняют внутривенные инъекции лекарственного препарата Цераксон (цитидин-5-дифосфохолин) с последующей электростимуляцией сетчатки и зрительного нерва в течение 10 дней. A method for the complex treatment of refractive amblyopia in patients with high myopia, including Epi-LASIK excimer laser refractive surgery, characterized in that in the postoperative period, intravenous injections of the drug Ceraxon (cytidine-5-diphosphocholine) are performed followed by electrical stimulation of the retina and optic nerve for 10 days.
RU2011150950/14A 2011-12-14 2011-12-14 Method of complex treatment of refractive amblyopia in patients with high degree of myopia RU2493803C2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU2011150950/14A RU2493803C2 (en) 2011-12-14 2011-12-14 Method of complex treatment of refractive amblyopia in patients with high degree of myopia

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2011150950/14A RU2493803C2 (en) 2011-12-14 2011-12-14 Method of complex treatment of refractive amblyopia in patients with high degree of myopia

Publications (2)

Publication Number Publication Date
RU2011150950A true RU2011150950A (en) 2013-06-20
RU2493803C2 RU2493803C2 (en) 2013-09-27

Family

ID=48785149

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2011150950/14A RU2493803C2 (en) 2011-12-14 2011-12-14 Method of complex treatment of refractive amblyopia in patients with high degree of myopia

Country Status (1)

Country Link
RU (1) RU2493803C2 (en)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19938203A1 (en) * 1999-08-11 2001-02-15 Aesculap Meditec Gmbh Method and device for correcting visual defects in the human eye
RU2302844C1 (en) * 2005-12-27 2007-07-20 ЗАКРЫТОЕ АКЦИОНЕРНОЕ ОБЩЕСТВО "ОПТИМЕДСЕРВИС" (ЗАО "Оптимедсервис") Laser correction method for treating moderate or high degree myopia cases when cornea thickness is insufficient
RU2336062C1 (en) * 2007-04-23 2008-10-20 Галина Ивановна Должич Method of treatment of compount difficult myopic astigmatism

Also Published As

Publication number Publication date
RU2493803C2 (en) 2013-09-27

Similar Documents

Publication Publication Date Title
EA201492031A1 (en) METHODS OF TREATMENT OF DIABETIC RETINOPATHY AND OTHER OPHTHALMOLOGICAL DISEASES
EA201590902A1 (en) METHODS AND DEVICES APPLICABLE FOR THE TREATMENT OF EYE DISEASES IN HUMAN
MX2021006092A (en) Use of a vegf antagonist to treat angiogenic eye disorders.
MX361858B (en) Ophthalmic formulation of polyoxyl lipid or polyoxyl fatty acid and treatment of ocular conditions.
EP2778749A3 (en) Presbyopia lens with pupil size correction based on level of refractive error
MX360683B (en) (bacterio)chlorophyll photosensitizers for treatment of eye diseases and disorders.
CY1120642T1 (en) PHARMACEUTICAL COMPOSITION OF IBUPROFEMEN AND TRAMADOL FOR OPHTHALMOLOGICAL USE
WO2012145428A3 (en) Altering protein concentrations in cerebrospinal fluid and/or brain interstitial fluid
WO2016060917A3 (en) Formulations for histatin therapeutics
CY1123344T1 (en) METHODS OF TREATMENT OF OTHLIC CONDITIONS WITH A SUSTAINED DRUG-RELEASE IMPLANT
MX2016016090A (en) Ophthalmic composition for the treatment of ocular infection.
AR092842A1 (en) TREATMENT OF OCULAR INFLAMMATORY DISEASES USING LAQUINIMOD
EA201600469A1 (en) PHARMACEUTICAL PREPARATION FOR PREVENTION AND TREATMENT OF PROGRESSIVE PATTERNS
BR112018072711A2 (en) process for providing neuroprotective therapy for glaucoma, and system for providing neuroprotective treatment for glaucoma
RU2011150950A (en) METHOD FOR INTEGRATED TREATMENT OF REFRACTION AMBLIOPIA IN HIGH DEGREE MYOPIA PATIENTS
EA201690903A1 (en) TREATMENT GLAUCOMA USING LAQUINIMODE
RU2010133699A (en) METHOD FOR COMBINED TREATMENT OF GLAUCOMA OPTICAL NEUROPATHY
RU2009107387A (en) METHOD FOR TREATING CATARACTS OF PATIENTS WITH DYSTROPHIC DISEASES OF THE RETAIL
RU2015154876A (en) METHOD FOR SURGICAL TREATMENT OF DIABETIC MACULAR Edema WITH VITREOMACULAR TRACTION
EA201600229A1 (en) BIS (5-AMINO-1,4-DIOXO-1,2,3,4-TETRAHYDRO-PHTHALAZIN-2-AIHs) ZINC, METHOD FOR ITS OBTAINING, PHARMACEUTICAL COMPOSITION ON ITS BASIS, MEDICAL MEANS ON ITS BASIS, SPECIAL SYSTEMS AND HEATS ARE BASED, ITEM-BASED, MEDICAL MEANS ON ITS BASIS, SPECIAL TESTS TREATMENT OF GASTRITIS
UA27832U (en) Method for treating dystrophic and vascular diseases of retina and optic nerve
RU2013125864A (en) HIGH DEGREE PROGRESSING MYOPIA TREATMENT METHOD
RU2011102742A (en) METHOD FOR TREATING INVOLUTIONAL EYE DISEASES
RU2007100519A (en) METHOD FOR TREATING COSOGLASION IN CHILDREN
RU2012129496A (en) METHOD FOR TREATING KERATOCONUS

Legal Events

Date Code Title Description
MM4A The patent is invalid due to non-payment of fees

Effective date: 20131215